secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medpace Holdings, Inc. (MEDP)
CIK:        0001668397
Form:       8-K
Filed at:   2023-01-18T23:59:59+00:00
Accession:  0001193125-23-010261
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Medpace appoints Dr. Femida H. Gwadry-Sridhar as new Class I director
---------------------------------------------------------------------

- Dr. Gwadry-Sridhar appointed to Board effective Jan 16, 2023, filling a Class I vacancy.
- She is CEO of Pulse Infoframe, a real-world evidence company, with academic roles at Western University and USC.
- Received an option to purchase 573 shares at Jan 13 closing price, with 7-year term.
- Expected to serve on the Nominating and Governance Committee.
- Participates in standard non-employee director compensation program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668397/000119312523010261/0001193125-23-010261-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668397/000119312523010261/d425623d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-010261

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer